Apr 22, 2022
CNS Pharmaceuticals (NASDAQ: CNSP) is leading the charge toward advancing research on the treatment for glioblastoma multiforme (“GBM”) as well as other primary and metastatic brain and CNS cancers. Last year, the company commenced a potentially pivotal clinical trial of its lead product candidate, Berubicin, for the treatment of GBM, dosing its first patients in September. A recent article discussing this reads, “CNS Pharmaceuticals expects to report an interim analysis of the trial when 30-50% of the planned subjects reach six months in-study, potentially in the first half of 2023. The adaptive, multicenter, open-label, randomized, and controlled study will involve about 243 adult patients with recurrent GBM after failure of standard first-line therapy. The subjects will be randomized in a 2:1 ratio to receive Berubicin or lomustine, a compound used in chemotherapy, to evaluate overall survival, the study’s primary endpoint. The study is expected to potentially build on the phase 1 trial and pharmacokinetic study of Berubicin, whose results revealed that 44% of the patients showed clinical response of stable disease or better, with one patient demonstrating a lack of detectable cancer cells and two patients with partial tumor reduction of up to 80%.
To view the full article, visit https://ibn.fm/FLko0
About CNS Pharmaceuticals Inc.
CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Additionally, the company is advancing the development of its WP1244 drug technology portfolio, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of WP1244 in the treatment of brain cancers, pancreatic, ovarian, and lymphomas. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
North Korea’s weightlifters will flex their considerable collective muscle when they return to the Olympics for the first time in 12 years at Los Angeles in 2028 – and they could be in for an American gold rush if the Asian Games are any indication. The secretive nation has been the dominant force in global weightlifting since emerging from self-imposed Covid exile to smash six world records at the Hangzhou Asian Games in 2023. They also won six golds. At the Aichi-Nagoya Asian Games in Japan...
Tennis legend Billie Jean King and two former professionals acknowledged modern players are suffering from burnout, but believed any change would be affected by the differing needs of elite players and rest, and the commercial pressure of tournaments. At present, WTA rules say players ranked in the top 30 must compete in all grand slams and ten WTA 1000 tournaments, and skipping these events results in ranking penalties and heavy financial fines that directly damage world standings and core...
Karis Teetan is confident Galaxy Patch can replicate his stable debut for Brett Crawford late last season and figure prominently when he returns in Sunday’s Group Three Celebration Cup (1,400m) at Sha Tin. A multiple Group winner and Group One placegetter for Pierre Ng Pang-chi, Galaxy Patch made an impressive first appearance for Crawford in the Group Three Premier Cup (1,400m) in June when he stormed home for a close second to Little Paradise. There is a 4lb swing on that race in favour of...
The battle for mixed doubles gold in squash will be an all-Hong Kong affair at the Asian Games on Sunday, after the city’s duos both won their semi-finals on a day when the city’s athletes picked up another three bronze medals and some semblance of normality returned to table tennis. With swimming finally over at the Tokyo Aquatics Centre, it was the turn of the divers to take centre stage, and to the surprise of absolutely no one, China won the two gold medals on offer on Saturday, the first of...
Japan’s 11-year-old esports prodigy Yuki Kurihara said he was “embarrassed” after winning Asian Games gold on Saturday by thrashing a series of opponents up to three times his age. The bespectacled primary school student, believed to be the youngest competitor at the Games in Aichi-Nagoya, won the Puyo Puyo Champions final 10-2. He is the youngest athlete in host country Japan’s Asian Games history. Puyo Puyo Champions is a puzzle game where players try to clear their screen of coloured blobs by...
Excited by the opportunity to reunite with Invincible Ibis, Luke Ferraris hopes the Hong Kong Derby (2,000m) hero can launch his latest campaign with a bang in Sunday’s Group Three Celebration Cup (1,400m) at Sha Tin. It has been 12 months since the South African jockey rode Mark Newnham’s promising galloper to his third placing from as many starts, with the son of Hellbent then reeling off four straight victories to emerge as a serious Classic Series contender. He followed up a second to Stormy...
“Woo-hoooo!” The cheers swirled as Wu Yibing ended the rally with a blistering forehand winner down the line. The first syllable was emphatically articulated, signalling that this was an intentional play on Wu’s last name, not a random shout after one too many honey deuces. It was Wu’s second-round match against Australian James Duckworth at the US Open earlier this month. Wu’s most vocal supporters turned out to be three white Americans sitting behind the baseline. Widely considered the most...
Manchester City plan to fight the Premier League for months if found guilty of alleged financial breaches in potentially the biggest scandal in English football history. Reports on Friday said an independent panel had upheld nearly all of the 100-plus financial charges against the club in a case that was initiated more than three years ago. City did not confirm the decision, saying their case with the Premier League was “ongoing”. City, however, would appeal against a guilty decision and the...
The Aichi-Nagoya Asian Games may only be halfway through, but the swimmers checked out of the Tokyo Aquatics Centre on Friday. An extended rest was probably too much of a luxury for most of them with the Swimming World Cup just around the corner. A trio of three-day meets in Baku, Tashkent and Astana from the start of next month will also act as qualifiers for the short course World Aquatics Swimming Championships, which run in Beijing from December 1 to 6. Four swimmers, two each from Japan and...
Teenage juggernaut Zhang Zhanshuo became the first swimmer to win seven gold medals at an Asian Games on the final night at the Tokyo pool on Friday, when China cemented their superpower status. Sitting on a lane divider, the 19-year-old Zhang counted out the golds with his fingers to mark the moment after cruising to the 400 metres freestyle title in a Games record of three minutes, 41.28 seconds, with Japan’s Kazushi Imafuku a distant runner-up. Having already won the 200m, 400m and 1,500m...
After 28 years and 50,000 kilometres (31,000 miles), a British adventurer is facing one last hurdle in his bid to trek home from South America without using any form of transport: the Channel. “We thought we got permission to swim from the coast of France. Turned out that is not the case,” Karl Bushby, a former paratrooper, said as he walked towards Cap Blanc-Nez in northern France, within sight of the white cliffs of the English coast. “There was some internal confusion. So, right now we’re...
Showing that age is not a constraint, 51-year-old Uzbekistan gymnast Oksana Chusovitina capped off her seventh Asian Games appearance with a fifth-place finish – 32 years after her first appearance at the regional event. Competing against athletes young enough to be her daughter, Chusovitina – who made her bow at the 1994 Hiroshima Games – more than held her own in the women’s vault artistic gymnastics final. Among the 19 athletes competing in the women’s vault on Thursday, 12 were under 21...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.